ACA Preventive Services Are Back at the Supreme Court: Kennedy v. Braidwood July 17, 2025 Issue Brief This brief provides an overview of the most recent ACA case under review at the Supreme Court (Kennedy v. Braidwood Management) and discusses the implications of the potential rulings by the high court.
Explaining Litigation Challenging the ACA’s Preventive Services Requirements: Braidwood Management Inc. v. Becerra July 17, 2025 Issue Brief This brief explains the preventive services coverage requirements, the basis of the Braidwood Management Inc. v. Becerra lawsuit, next steps in the litigation, and the potential implications.
Access to OB-GYNs: Evaluating Workforce Supply and ACA Marketplace Networks July 10, 2025 Issue Brief This brief examines the supply of OB-GYNs in the U.S. and the share of OB-GYNs participating in the provider networks of Qualified Health Plans (QHPs) offered in the individual market in the federal and state Affordable Care Act (ACA) Marketplaces in 2021.
States Expand Access to Ivermectin as Cancer Myths Continue, and Abortion Pill Faces False Water Supply Claim — The Monitor July 10, 2025 Page This volume examines unsupported claims about ivermectin; the promotion of unproven “detox” supplements in response to falsehoods about the spike protein from the COVID-19 virus and vaccine; the unsubstantiated claim that byproducts from medication abortion pills contaminate the water supply; and the renewed debate over ADHD diagnoses and treatments.
10 Key Data Points About the Experiences of LGBT+ Women and Their Access to Care June 30, 2025 Issue Brief This brief presents key data points on the health care experiences of LGBT+ women from the KFF Women’s Health Survey, a nationally representative survey of women in the United States conducted from May 13 – June 18, 2024.
Flawed Report Aims to Undercut Established Research on Abortion Pill Safety, Plus How a Federal Initiative to Study Autism May Overemphasize Environmental Toxins — The Monitor June 12, 2025 Page This volume highlights how a report criticized for flawed methodology is influencing renewed efforts to restrict access to mifepristone; a federal plan to study the causes of autism that could be contributing to stigma by over-emphasizing environmental toxins; and the resurgence of false claims about fetal tissue in vaccines.
5 Key Facts About Medicaid and Family Planning May 29, 2025 Issue Brief Amid debates to limit federal Medicaid support, this brief presents five facts to know about Medicaid’s role for family planning.
Women’s Experiences with Intimate Partner Violence May 6, 2025 Issue Brief This analysis provides data on women experiencing intimate partner violence (IPV) and reports on a range of health topics affecting women who experienced IPV in the past five years, including their health care needs and use, barriers, and mental health.
KFF Global Health Budget Summaries May 2, 2025 Fact Sheet These global health budget summaries highlight key information about global health funding levels throughout the federal budget and appropriations process.
COVID Vaccine Concerns and Claims About Ivermectin as Cancer Treatment — The Monitor March 13, 2025 Page This volume covers recent claims about COVID vaccine safety after a new study describes a rare condition it calls “post-vaccination syndrome” (PVS). It also investigates the false claim that ivermectin can treat cancer and highlights the re-emergence of concerns online about Gardasil, and its alleged mortality rate.